Learn More
Endocrine therapy is a key treatment strategy to control or eradicate hormone-responsive breast cancer. However, resistance to endocrine therapy leads to breast cancer relapse. The recent extension of adjuvant tamoxifen treatment up to 10 years actualizes the need for identifying biological markers that may be used to monitor predictors of treatment(More)
The article reports a case of pseudolymphoma of the stomach. The histological hallmark is lymphoid hyperplasia, with formation of reactive follicles. Most authors believe that this is a benign disorder. The exuberance of the lymphoid reaction may be misinterpreted, however, as malignant lymphoma, which may possibly explain the unduly good prognosis reported(More)
  • 1